Note 11 - Share Based Compensation and Employee Benefit Plans - Non-vested Restricted Stock Awards and RSU's (Details) - Restricted Stock [Member]	12 Months Ended
	Dec. 31, 2023 USD ($) $ / shares shares
Outstanding non-vested shares (in shares) | shares	1,128,981
Outstanding non-vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 27.92
Granted (in shares) | shares	572,804
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	$ 36.97
Vested (in shares) | shares	(627,393)
Vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 24.67
Outstanding non-vested shares (in shares) | shares	1,074,392
Outstanding non-vested, weighted average remaining contractual life (Year)	8 years 7 months 6 days
Outstanding non-vested, aggregate intrinsic value | $	$ 56,921,288
Outstanding non-vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 34.64
Expected to vest (in shares) | shares	1,071,636
Expected to vest, weighted average remaining contractual life (Year)	8 years 7 months 6 days
Expected to vest, aggregate intrinsic value | $	$ 56,775,267
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 34.64